AAAAAA

   
Results: 1-7 |
Results: 7
ACYCLOVIR USE AND SURVIVAL AMONG HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS WITH CD4 CELL COUNTS OF LESS-THAN-500 MM(3)/
Authors: TORRES RA NEATON JD WENTWORTH DN BARR MR ABRAMS D SHERER R WARD T SAMPSON J
Citation: Ra. Torres et al., ACYCLOVIR USE AND SURVIVAL AMONG HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS WITH CD4 CELL COUNTS OF LESS-THAN-500 MM(3)/, Clinical infectious diseases, 26(1), 1998, pp. 85-90
LOW SERUM-CHOLESTEROL AND RISK OF DEATH FROM AIDS
Authors: NEATON JD WENTWORTH DN
Citation: Jd. Neaton et Dn. Wentworth, LOW SERUM-CHOLESTEROL AND RISK OF DEATH FROM AIDS, AIDS, 11(7), 1997, pp. 929-930
CIGARETTE-SMOKING, BACTERIAL PNEUMONIA, AND OTHER CLINICAL OUTCOMES IN HIV-1 INFECTION
Authors: BURNS DN HILLMAN D NEATON JD SHERER R MITCHELL T CAPPS L VALLIER WG THURNHERR MD GORDIN FM JOHNS S ELLISON J HICKSON MJ LEE J THOMPSON M CREAGH T MORRIS A ERNST J POLLARD C ANASTOS K BAR M DORAMAJIAN E BLATT D MOORE D RENZETTI R VERHEGGEN R LUSKINHAWK R TORRES RA TOWNLEY D CLANON K MORRIS B OWEN W BROSGART C CRANE LR EBRIGHT J SCHUMAN P VALLIER W FAIRCLOUGH C HOLLOWAY WJ WINSLOW D SZABO S BINCSIK A SWANSON K COHN DL REVES RR GRODESKY MJ MESARD CA GANS JE ELSADR W CAPPS L GUITY C HARDY M FUENTES L SARAVOLATZ L MARKOWITZ N KUMI J MASTROPOLAK D RYDER R VOGEL R HUTCHINSON J WALKER J PABLOVICH S SIMMONS P KIMMEL N KOCHER J WEISHOLTZ S SHERIDAN A TAYLOR VM BRAITHWAITE J SAMPSON JH GODBEY J LOVELESS M SALVESON C MARTINEZ N KERKERING TM WEBSTER C FISHER E LINK K GERNON L LABRIOLA A GIBERT C SCOTT J FINLEY E IRVIN K LOUIS TA BRELJE T DUCHENE A THOMPSON G WENTWORTH DN DEYTON LR SANVILLE J FOULKES M
Citation: Dn. Burns et al., CIGARETTE-SMOKING, BACTERIAL PNEUMONIA, AND OTHER CLINICAL OUTCOMES IN HIV-1 INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 13(4), 1996, pp. 374-383
DATA-ANALYSIS ISSUES FOR PROTOCOLS WITH OVERLAPPING ENROLLMENT
Authors: LARNTZ K NEATON JD WENTWORTH DN YURIK T
Citation: K. Larntz et al., DATA-ANALYSIS ISSUES FOR PROTOCOLS WITH OVERLAPPING ENROLLMENT, Statistics in medicine, 15(21-22), 1996, pp. 2445-2453
RISK-FACTORS AND ALL-CAUSE, CARDIOVASCULAR-DISEASE, AND CORONARY-HEART-DISEASE MORTALITY IN BLACKS, WHITES, HISPANICS AND ASIAN-PACIFIC MEN, AGE 35-57
Authors: KULLER LH NEATEN JD WENTWORTH DN CUTLER JA
Citation: Lh. Kuller et al., RISK-FACTORS AND ALL-CAUSE, CARDIOVASCULAR-DISEASE, AND CORONARY-HEART-DISEASE MORTALITY IN BLACKS, WHITES, HISPANICS AND ASIAN-PACIFIC MEN, AGE 35-57, Circulation, 91(3), 1995, pp. 937-937
CONSIDERATIONS IN CHOICE OF A CLINICAL END-POINT FOR AIDS CLINICAL-TRIALS
Authors: NEATON JD WENTWORTH DN RHAME F HOGAN C ABRAMS DI DEYTON L
Citation: Jd. Neaton et al., CONSIDERATIONS IN CHOICE OF A CLINICAL END-POINT FOR AIDS CLINICAL-TRIALS, Statistics in medicine, 13(19-20), 1994, pp. 2107-2125
PRIMARY PROPHYLAXIS WITH PYRIMETHAMINE FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - RESULTS OF A RANDOMIZED TRIAL
Authors: JACOBSON MA BESCH CL CHILD C HAFNER R MATTS JP MUTH K WENTWORTH DN NEATON JD ABRAMS D RIMLAND D PEREZ G GRANT IH SARAVOLATZ LD BROWN LS DEYTON L
Citation: Ma. Jacobson et al., PRIMARY PROPHYLAXIS WITH PYRIMETHAMINE FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - RESULTS OF A RANDOMIZED TRIAL, The Journal of infectious diseases, 169(2), 1994, pp. 384-394
Risultati: 1-7 |